Guardant Health, Inc. (GH) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Diagnostics & Research उद्योग. कंपनी का मुख्यालय है Palo Alto, CA, United States. वर्तमान CEO हैं Helmy Eltoukhy.
GH के पास है IPO तिथि 2018-10-04, 1,999 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $11.13B.
Guardant Health, Inc. is a precision oncology company that develops and provides innovative blood-based liquid biopsy tests and analytics for cancer detection and treatment. The company offers a portfolio of products including Guardant360 and its variants for advanced-stage cancer patients, GuardantINFORM for clinical genomic research, and LUNAR-2 for early colorectal cancer detection, as well as GuardantConnect, a software platform connecting patients with relevant clinical trials. Additionally, Guardant Health provides development services to biopharmaceutical companies and medical institutions, including companion diagnostic development, clinical trial support, and testing solutions. Headquartered in Redwood City, California, the company operates globally and serves the oncology market through its comprehensive suite of diagnostic and data analytics offerings.
